Muckle-Wells syndrome (MWS)
Jump to navigation
Jump to search
Epidemiology
- rare
- onset in childhood
- affects persons of European descent
Pathology
Genetics
- autosomal dominant
- mutation in CIAS1 gene
Clinical manifestations
- periodic fever
- episodic urticaria-like rash
- arthralgia, oligoarthritis
- abdominal pain
- pleuritis is rare
- conjunctivitis
- amyloidosis
- progressive sensorineural hearing loss
Laboratory
Management
- interleukin 1-beta inhibitor[2]
- rilonacept
- canakinumab (Ilaris) FDA-approved in 2009